These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 39066415)

  • 1. Enhanced Immune Responses in Mice by Combining the Mpox Virus B6R-Protein and Aluminum Hydroxide-CpG Vaccine Adjuvants.
    Li J; Li X; Dong J; Wei J; Guo X; Wang G; Xu M; Zhao A
    Vaccines (Basel); 2024 Jul; 12(7):. PubMed ID: 39066415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel BC02 Compound Adjuvant Enhances Adaptive and Innate Immunity Induced by Recombinant Glycoprotein E of Varicella-Zoster Virus.
    Li J; Fu L; Guo X; Yang Y; Dong J; Wang G; Zhao A
    Vaccines (Basel); 2022 Dec; 10(12):. PubMed ID: 36560565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Subunit Vaccine Candidate Composed of Mpox Virus A29L, M1R, A35R, and B6R Elicits Robust Immune Response in Mice.
    Yang X; Yang X; Du S; Hu C; Yang X; Wang X; Hu X; Rcheulishvili N; Wang PG; Lin J
    Vaccines (Basel); 2023 Aug; 11(9):. PubMed ID: 37766097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced Potency and Persistence of Immunity to Varicella-Zoster Virus Glycoprotein E in Mice by Addition of a Novel BC02 Compound Adjuvant.
    Li J; Fu L; Yang Y; Wang G; Zhao A
    Vaccines (Basel); 2022 Mar; 10(4):. PubMed ID: 35455278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic evaluation of the induction of efficient neutralizing antibodies by recombinant multicomponent subunit vaccines against monkeypox virus.
    Tan M; Zhang R; Shen T; Li A; Hou X; Zhang Y; Wang T; Zhang B; Sun P; Gong X; Li L; Wu J; Wu J; Zhang R; Liu B
    Vaccine; 2024 Sep; 42(26):126384. PubMed ID: 39321566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyvalent mpox mRNA vaccines elicit robust immune responses and confer potent protection against vaccinia virus.
    Ye T; Zhou J; Guo C; Zhang K; Wang Y; Liu Y; Zhou J; Xie Y; Li E; Gong R; Zhang J; Chuai X; Chiu S
    Cell Rep; 2024 Jun; 43(6):114269. PubMed ID: 38787725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the Immune Responses to Different Formulations of BC02-Adjuvanted HPV Types 16 and 18 Bivalent Vaccines in Mice.
    Li J; Xie H; Fu L; Guo X; Dong J; Xu M; Wang G; Zhao A
    Vaccines (Basel); 2023 Sep; 11(10):. PubMed ID: 37896956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polycation-decorated PLA microspheres induce robust immune responses via commonly used parenteral administration routes.
    Chen X; Wang L; Liu Q; Jia J; Liu Y; Zhang W; Ma G; Su Z
    Int Immunopharmacol; 2014 Dec; 23(2):592-602. PubMed ID: 25466267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic modified vaccinia Ankara vaccines confer cross-reactive and protective immunity against mpox virus.
    Chiuppesi F; Zaia JA; Gutierrez-Franco MA; Ortega-Francisco S; Ly M; Kha M; Kim T; Dempsey S; Kar S; Grifoni A; Sette A; Wussow F; Diamond DJ
    Commun Med (Lond); 2024 Feb; 4(1):19. PubMed ID: 38366141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation and comparison of immune responses induced by two Mpox mRNA vaccine candidates in mice.
    Yang X; Hu C; Yang X; Yang X; Hu X; Wang X; Liu C; Yuan Y; Du S; Wang PG; Lin J
    J Med Virol; 2023 Oct; 95(10):e29140. PubMed ID: 37800627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant proteins A29L, M1R, A35R, and B6R vaccination protects mice from mpox virus challenge.
    Tang D; Liu X; Lu J; Fan H; Xu X; Sun K; Wang R; Li C; Dan D; Du H; Wang Z; Li X; Yang X
    Front Immunol; 2023; 14():1203410. PubMed ID: 37435062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic Toll-like receptor 4 (TLR4) and TLR7 ligands as influenza virus vaccine adjuvants induce rapid, sustained, and broadly protective responses.
    Goff PH; Hayashi T; Martínez-Gil L; Corr M; Crain B; Yao S; Cottam HB; Chan M; Ramos I; Eggink D; Heshmati M; Krammer F; Messer K; Pu M; Fernandez-Sesma A; Palese P; Carson DA
    J Virol; 2015 Mar; 89(6):3221-35. PubMed ID: 25568203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational development of multicomponent mRNA vaccine candidates against mpox.
    Zhang RR; Wang ZJ; Zhu YL; Tang W; Zhou C; Zhao SQ; Wu M; Ming T; Deng YQ; Chen Q; Jin NY; Ye Q; Li X; Qin CF
    Emerg Microbes Infect; 2023 Dec; 12(1):2192815. PubMed ID: 36947428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duration of humoral immunity from smallpox vaccination and its cross-reaction with Mpox virus.
    Li E; Guo X; Hong D; Gong Q; Xie W; Li T; Wang J; Chuai X; Chiu S
    Signal Transduct Target Ther; 2023 Sep; 8(1):350. PubMed ID: 37709783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-delivery of a trimeric spike DNA and protein vaccine with aluminum hydroxide enhanced Th1-dominant humoral and cellular immunity against SARS-CoV-2.
    Liao HC; Huang MS; Chiu FF; Chai KM; Liao CL; Wu SC; Chen HW; Liu SJ
    J Med Virol; 2023 Aug; 95(8):e29040. PubMed ID: 37635380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bovine immune response to leptospira antigen in different novel adjuvants and vaccine delivery platforms.
    Wilson-Welder JH; Boggiatto P; Nally JE; Wafa EI; Alt DP; Hornsby RL; Frank A; Jones DE; Olsen SC; Bowden NB; Salem AK
    Vaccine; 2020 Apr; 38(18):3464-3473. PubMed ID: 32204939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant tuberculosis vaccine AEC/BC02 induces antigen-specific cellular responses in mice and protects guinea pigs in a model of latent infection.
    Lu JB; Chen BW; Wang GZ; Fu LL; Shen XB; Su C; Du WX; Yang L; Xu M
    J Microbiol Immunol Infect; 2015 Dec; 48(6):597-603. PubMed ID: 24863497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant use of the NKT cell agonist alpha-galactosylceramide leads to enhancement of M2-based DNA vaccine immunogenicity and protective immunity against influenza A virus.
    Fotouhi F; Shaffifar M; Farahmand B; Shirian S; Saeidi M; Tabarraei A; Gorji A; Ghaemi A
    Arch Virol; 2017 May; 162(5):1251-1260. PubMed ID: 28120096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An alphavirus-based adjuvant enhances serum and mucosal antibodies, T cells, and protective immunity to influenza virus in neonatal mice.
    Khalil SM; Tonkin DR; Snead AT; Parks GD; Johnston RE; White LJ
    J Virol; 2014 Aug; 88(16):9182-96. PubMed ID: 24899195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic Herpes Simplex Virus 2 (HSV-2) Vaccines Adjuvanted with Stable Emulsion and Toll-Like Receptor 9 Agonist Induce a Robust HSV-2-Specific Cell-Mediated Immune Response, Protect against Symptomatic Disease, and Reduce the Latent Viral Reservoir.
    Hensel MT; Marshall JD; Dorwart MR; Heeke DS; Rao E; Tummala P; Yu L; Cohen GH; Eisenberg RJ; Sloan DD
    J Virol; 2017 May; 91(9):. PubMed ID: 28228587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.